Literature DB >> 6376543

In vivo behavior of radioiodinated rabbit antithrombin III. Demonstration of a noncirculating vascular compartment.

T H Carlson, A C Atencio, T L Simon.   

Abstract

Rabbit antithrombin III (AT), purified by heparin-agarose, was labeled with iodine-131 by either the glucose oxidase-lactoperoxidase or iodine monochloride techniques. When intravenously injected, the disappearance of the 131I-AT from plasma was characterized by rapid initial decreases, and three-exponential equations were required for best fit of the plasma disappearance curves. This rapid 131I-AT removal was not caused by denaturation, as shown by comparison with results obtained when 131I-AT was biologically screened (injected into a first rabbit, and then transferred 16 h later in whole plasma to a second for kinetic evaluation) before injection. Thus, the same rapid initial loss of plasma 131I-AT was observed with screened preparations, and the plasma fractional catabolic rates of 0.716 +/- 0.048 and 0.673 +/- 0.051 day-1 for unscreened and screened 131I-AT were not significantly different. These results support the hypothesis that a vascular-endothelial AT compartment is present in rabbit. The fractions of the total-body AT in the plasma, the vascular-endothelial and the extravascular compartments were 0.337 +/- 0.031, 0.178 +/- 0.056, and 0.485 +/- 0.069, respectively. Two three-compartment kinetic models are discussed. The first pictures AT as distributing independently between plasma and two other compartments, and the second sees AT as first passing to the vascular-endothelial compartment, and then directly into the extravascular compartment. The plasma 131I-AT kinetic data was consistent with both models, but the sizes of the vascular-endothelial compartments were best predicted by the second. If AT catabolism was assigned to the plasma, both models generally underpredicted the whole-body radioactivities, while assignment of breakdown to the extravascular compartment generally resulted in overpredictions. This suggests that AT catabolism occurs from both plasma and extravascular compartments.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6376543      PMCID: PMC425200          DOI: 10.1172/JCI111401

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.

Authors:  O EGEBERG
Journal:  Thromb Diath Haemorrh       Date:  1965-06-15

2.  The theory of tracer experiments with 131I-labelled plasma proteins.

Authors:  C M MATTHEWS
Journal:  Phys Med Biol       Date:  1957-07       Impact factor: 3.609

3.  The turnover rate of serum albumin in man as measured by I131-tagged albumin.

Authors:  K STERLING
Journal:  J Clin Invest       Date:  1951-11       Impact factor: 14.808

4.  Binding of thrombin to antithrombin III.

Authors:  U Abildgaard
Journal:  Scand J Clin Lab Invest       Date:  1969-08       Impact factor: 1.713

Review 5.  Chemistry of the hemostatic mechanism and its relationship to the action of heparin.

Authors:  R D Rosenberg
Journal:  Fed Proc       Date:  1977-01

6.  Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III.

Authors:  P Lollar; W G Owen
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

7.  Isolation and partial characterization of two distinct types of antithrombin III from rabbit.

Authors:  T H Carlson; A C Atencio
Journal:  Thromb Res       Date:  1982-07-01       Impact factor: 3.944

8.  Studies of the effects of heparin, Coumadin, and vitamin K on prothrombin metabolism and distribution in calves with the use of iodine-125-prothrombin. Characterization of the prothrombin system.

Authors:  Y Takeda
Journal:  J Lab Clin Med       Date:  1970-03

9.  The kinetics of the distribution and breakdown of 1131-albumin in the rabbit. Observations on several mathematical descriptions.

Authors:  E B REEVE; J E ROBERTS
Journal:  J Gen Physiol       Date:  1959-11       Impact factor: 4.086

10.  The nature and rates of excretion of radioactive breakdown products of I131-albumin in the rabbit.

Authors:  F ZIZZA; T J CAMPBELL; E B REEVE
Journal:  J Gen Physiol       Date:  1959-11       Impact factor: 4.086

View more
  7 in total

1.  Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis.

Authors:  Sassan HajMohammadi; Keiichi Enjyoji; Marc Princivalle; Patricia Christi; Miroslav Lech; David Beeler; Helen Rayburn; John J Schwartz; Samad Barzegar; Ariane I de Agostini; Mark J Post; Robert D Rosenberg; Nicholas W Shworak
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation.

Authors:  S E Lind; D B Smith; P A Janmey; T P Stossel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

Review 3.  Clearance of thrombin in vivo: significance of alternative pathways.

Authors:  T H Carlson
Journal:  Mol Cell Biochem       Date:  1986-08       Impact factor: 3.396

4.  Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cells.

Authors:  Feng-Pai Chou; Han Xu; Ming-Shyue Lee; Ya-Wen Chen; O X Durand Richards; Richard Swanson; Steven T Olson; Michael D Johnson; Chen-Yong Lin
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-27       Impact factor: 4.249

5.  Comparison of the behaviour in vivo of two molecular forms of antithrombin III.

Authors:  T H Carlson; A C Atencio; T L Simon
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

6.  Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.

Authors:  K A Bauer; T L Goodman; B L Kass; R D Rosenberg
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

7.  Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta.

Authors:  A I de Agostini; S C Watkins; H S Slayter; H Youssoufian; R D Rosenberg
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.